Montelukast is FDA-approved to treat allergies, specifically allergic rhinitis in both its seasonal and year-round forms. Sold under the brand name Singulair, it works differently from antihistamines and nasal sprays, making it a useful option for some people, though it’s generally not the first choice for allergies alone. A boxed warning about serious mental health side effects means it’s typically reserved for patients who haven’t responded well to other treatments.
What Montelukast Does in the Body
Montelukast belongs to a class of drugs called leukotriene receptor antagonists. When your body encounters an allergen, immune cells produce chemicals called leukotrienes from fatty acids in cell membranes. These leukotrienes latch onto receptors in your airways and nasal passages, triggering a chain of inflammatory responses: swelling of the nasal lining, increased mucus production, recruitment of immune cells that sustain the inflammation, and constriction of the airways.
Montelukast blocks the receptor (called CysLT1) where these leukotrienes dock. By doing so, it interrupts the inflammatory cascade before it produces symptoms. This is fundamentally different from antihistamines, which block a separate chemical messenger called histamine. Because allergies involve both histamine and leukotrienes, the two types of medication target different parts of the same allergic response.
Approved Uses for Allergies
The FDA has approved montelukast for two allergy-related conditions:
- Seasonal allergic rhinitis (hay fever) in patients aged 2 and older
- Perennial allergic rhinitis (year-round allergies to dust mites, pet dander, mold) in patients as young as 6 months
Montelukast is also approved for chronic asthma in patients 12 months and older and for prevention of exercise-induced breathing difficulty. If you have both asthma and allergic rhinitis, a single daily dose covers both conditions.
How It Compares to Antihistamines
For most people with allergic rhinitis, montelukast is not as effective as a second-generation antihistamine like cetirizine or loratadine. A systematic review and meta-analysis found no significant difference between the two in overall symptom scores, but antihistamines performed better at reducing daytime symptoms. Montelukast did show a slight edge over antihistamines for nighttime symptoms, which may matter if nasal congestion is disrupting your sleep.
Combining montelukast with an antihistamine was more effective for daytime symptoms than montelukast alone. Current international guidelines from the ARIA consortium (Allergic Rhinitis and its Impact on Asthma) reflect this hierarchy: nasal corticosteroid sprays are the top recommendation, followed by oral antihistamines, with montelukast ranked below both. The guidelines also recommend against routinely adding montelukast on top of an antihistamine.
That said, rankings describe averages across large groups. Some individuals respond better to leukotriene blockers than antihistamines, particularly people whose allergies involve significant nasal congestion or who also have asthma. Montelukast also avoids the drowsiness that some antihistamines can cause. One meta-analysis noted patients taking montelukast may experience lower rates of fatigue compared to antihistamine users.
Use in Chronic Hives
Montelukast is sometimes prescribed off-label for chronic hives (chronic urticaria) that don’t respond to antihistamines alone. Clinical consensus guidelines support adding a leukotriene receptor antagonist when antihistamines aren’t enough. It has been used for several subtypes including cold-triggered hives, pressure-related hives, and chronic hives with no identifiable cause. Small studies have shown that most patients experience improvement when montelukast is added to their existing antihistamine regimen, though it works best as an add-on rather than a standalone treatment for hives.
Dosage and How to Take It
Montelukast is taken once daily as a tablet, chewable tablet, or oral granules depending on age. Standard doses for allergic rhinitis:
- Adults and teens 15+: 10 mg tablet
- Children 6 to 14: 5 mg chewable tablet
- Children 2 to 5 (seasonal) or 6 months to 5 (perennial): 4 mg chewable tablet or oral granules
When you’re taking it for allergies rather than asthma, you can take it at any time of day, morning or evening. For asthma, evening dosing is recommended. If you have both conditions, take it in the evening. Relief can begin after the first dose, and the effect lasts a full 24 hours.
The Boxed Warning on Mental Health
The FDA added its most serious warning, a boxed warning, to montelukast’s prescribing information. This was prompted by reports of significant mental health side effects, including agitation, depression, sleep disturbances, suicidal thoughts, and in rare cases, completed suicides. These events have occurred in patients with no prior history of mental health conditions.
Because of this warning, the FDA advises that montelukast should not be used as a first-line treatment for allergic rhinitis. It should be reserved for patients who have not responded adequately to, or cannot tolerate, other allergy medications. For asthma, where fewer alternative medications exist, the risk-benefit calculation is different, and montelukast remains a more common choice.
If you’re currently taking montelukast for allergies and it’s working well without side effects, that doesn’t necessarily mean you need to stop. But it’s worth knowing that mood changes, unusual dreams, irritability, or new anxiety while taking this medication are reasons to contact your prescriber promptly. These effects can appear at any point during treatment, not just in the first few weeks.
Where Montelukast Fits in Allergy Treatment
Montelukast occupies a specific niche. It’s not the most powerful allergy medication, and the mental health warning means it carries more risk than an over-the-counter antihistamine. But for certain patients, it fills a real gap. People whose main complaint is nasal congestion rather than sneezing or itching may benefit because leukotrienes play a larger role in swelling than histamine does. People with coexisting asthma get dual benefit from a single pill. And people who find antihistamines ineffective or intolerable have a mechanistically different option.
If you’ve been prescribed montelukast for allergies, it likely means your doctor has considered and ruled out simpler alternatives. If you’re wondering whether to ask about it, the practical question is whether nasal sprays and antihistamines have been given a fair trial first. For most people, those two categories handle allergic rhinitis well. Montelukast is the next step when they don’t.